BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 11
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 27
• 28
• 29
• 30

• GTx, Inc. Announces 1-for-10 Reverse Stock Split

  December 5, 2016

   · 

  3 min read
• BioForest

  Omeros’ Proprietary Orphan GPCR Program Delivers New Target And Approach In Cancer Immunotherapy

  December 5, 2016

   · 

  8 min read
• Business

  Xenetic Biosciences Expands Management Team With Key Appointment Of Jeffrey F. Eisenberg As Chief Operating Officer

  December 5, 2016

   · 

  6 min read
• Drug Development

  Syros Pharma Presents Data At American Society of Hematology Annual Meeting Further Supporting Clinical Potential Of Its First-In-Class Selective Rara Agonist For Genomically Defined Subsets Of AML And MDS Patients

  December 5, 2016

   · 

  8 min read
• Drug Development

  Merck & Co. Release: Updated KEYTRUDA (Pembrolizumab) Findings In Patients With Relapsed Or Refractory Primary Mediastinal Large B-Cell Lymphoma Presented At 58th Annual Meeting Of The American Society of Hematology

  December 5, 2016

   · 

  17 min read
• Pharm Country

  Aethon, Inc. And Advanced Pharmaceuticals Provide Solution To Automate Operating Room Trays

  December 5, 2016

   · 

  2 min read
• BioMidwest

  Fresenius Kabi AG Introduces Tigecycline For Injection, US

  December 5, 2016

   · 

  2 min read
• Business

  NantHealth Continues Global Expansion Of GPS Cancer By Bringing Advanced Molecular Profiling To Patients In The Middle East Through Partnership With Lunatus

  December 5, 2016

   · 

  8 min read
• Drug Development

  Celltrion Healthcare Presents Positive Results For CT-P10, Biosimilar Rituximab Candidate, In Newly Diagnosed Advanced Stage Follicular Lymphoma

  December 5, 2016

   · 

  7 min read
• Drug Development

  Acetylon Presents Early Phase 1a/1b Results For Citarinostat (ACY-241) In Combination With Pomalyst And Dexamethasone Showing Promising Treatment Responses In Relapsed Or Relapsed-And-Refractory Multiple Myeloma

  December 5, 2016

   · 

  5 min read